RFL Rafael Holdings Inc
Price (delayed)
$2.05
Market cap
$50.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.66
Enterprise value
$44.81M
Rafael Holdings is focused on development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd. Through
Highlights
The revenue has soared by 152% YoY and by 9% from the previous quarter
Rafael Holdings's gross profit has soared by 83% YoY and by 4.8% from the previous quarter
Rafael Holdings's quick ratio has shrunk by 88% YoY and by 2.6% QoQ
Rafael Holdings's gross margin has decreased by 27% YoY and by 4.2% QoQ
Key stats
What are the main financial stats of RFL
Market
Valuations
Earnings
Shares outstanding
24.67M
Market cap
$50.58M
Enterprise value
$44.81M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.69
Price to sales (P/S)
70.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
64.29
Revenue
$697,000
Gross profit
$506,000
Operating income
-$103.99M
Net income
-$39.78M
EBIT
-$42.04M
EBITDA
-$41.75M
Free cash flow
-$8.86M
Per share
Balance sheet
Liquidity
EPS
-$1.66
EPS diluted
-$1.67
Free cash flow per share
-$0.37
Book value per share
$2.99
Revenue per share
$0.03
TBVPS
$3.45
Total assets
$87.84M
Total liabilities
$10.45M
Debt
$2.39M
Equity
$73.52M
Working capital
$63.24M
Debt to equity
0.03
Current ratio
9.74
Quick ratio
9.27
Net debt/EBITDA
0.14
Margins
Efficiency
Dividend
EBITDA margin
-5,989.7%
Gross margin
72.6%
Net margin
-5,707%
Operating margin
-14,920.1%
Return on assets
-40.5%
Return on equity
-46.2%
Return on invested capital
-51%
Return on capital employed
-52.2%
Return on sales
-6,031.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RFL stock price
How has the Rafael Holdings stock price performed over time
Intraday
3.02%
1 week
-0.49%
1 month
4.06%
1 year
10.22%
YTD
24.24%
QTD
24.24%
Financial performance
How have Rafael Holdings's revenue and profit performed over time
Revenue
$697,000
Gross profit
$506,000
Operating income
-$103.99M
Net income
-$39.78M
Gross margin
72.6%
Net margin
-5,707%
The revenue has soared by 152% YoY and by 9% from the previous quarter
The net margin has plunged by 122% YoY and by 6% from the previous quarter
Rafael Holdings's gross profit has soared by 83% YoY and by 4.8% from the previous quarter
Rafael Holdings's gross margin has decreased by 27% YoY and by 4.2% QoQ
Growth
What is Rafael Holdings's growth rate over time
Valuation
What is Rafael Holdings stock price valuation
P/E
N/A
P/B
0.69
P/S
70.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
64.29
The EPS has declined by 14% since the previous quarter
The P/B is 54% lower than the 5-year quarterly average of 1.5 but 38% higher than the last 4 quarters average of 0.5
RFL's equity is down by 22% YoY and by 11% QoQ
The revenue has soared by 152% YoY and by 9% from the previous quarter
The price to sales (P/S) is 58% lower than the 5-year quarterly average of 167.4 and 18% lower than the last 4 quarters average of 86.3
Efficiency
How efficient is Rafael Holdings business performance
The return on sales has dropped by 127% year-on-year and by 4.3% since the previous quarter
The ROE has contracted by 23% from the previous quarter
The ROIC is down by 18% since the previous quarter
RFL's ROA is down by 18% QoQ
Dividends
What is RFL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RFL.
Financial health
How did Rafael Holdings financials performed over time
RFL's current ratio has dropped by 88% year-on-year
Rafael Holdings's quick ratio has shrunk by 88% YoY and by 2.6% QoQ
The debt is 97% less than the equity
RFL's equity is down by 22% YoY and by 11% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.